| 摘要 |
Disclosed is the use of Bv8 polypeptide, a polynucleotide encoding Bv8 polypeptide, EG-VEGF polypeptide, a polynucleotide encoding EG-VEGF polypeptide, or a combination thereof in the preparation of a medicament for treating an immunodeficiency disorder Also disclosed is a use of a Bv8 polypeptide antagonist, EG-VEGF polypeptide antagonist, or a combination thereof in the preparation of a medicament for treating an autoimmune disorder or a disorder associated with abnormal hematopoiesis. Also disclosed is an in vitro method for inducing proliferation of bone marrow cells, lymphoid lineage progenitor cells, or progeny thereof, comprising contacting the cells with a Bv8 polypeptide or a polynucleotide encoding Bv8 polypeptide. |
